Last update 08 May 2025

TAVO PLUS-CD3

Overview

Basic Info

Drug Type
Biological products
Synonyms-
Target
CD3 x IL-12
Action
inhibitors, modulators
Mechanism
CD3 inhibitors(T cell surface glycoprotein CD3 inhibitors), IL-12 modulators(Interleukin-12 modulators)
Therapeutic Areas
Neoplasms
Active Indication-
Inactive Indication
Solid tumor
Originator Organization
OncoSec Medical, Inc.OncoSec Medical, Inc.
Active Organization-
Inactive Organization
OncoSec Medical, Inc.OncoSec Medical, Inc.
License Organization-
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with TAVO PLUS-CD3
Login to view more data
100 Translational Medicine associated with TAVO PLUS-CD3
Login to view more data
100 Patents (Medical) associated with TAVO PLUS-CD3
Login to view more data
100 Deals associated with TAVO PLUS-CD3
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Solid tumorPreclinical
United States
OncoSec Medical, Inc.OncoSec Medical, Inc.
22 Jun 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free